Grant of 13,000 RSUs to Spruce Biosciences (SPRB) Chief Medical Officer
Spruce Biosciences' Chief Medical Officer, Adrian W. Quartel, was granted 13,000 Restricted Stock Units (RSUs) on July 27, 2026. These RSUs, each representing one share of common stock, will vest 25% annually from 2027 through 2030, contingent on his continuous service. This grant aligns …